Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 181

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Endogenous TNFα Lowers Maximum Peak Bone Mass and Inhibits Osteoblastic Smad Activation Through NF-κB

Li, Yan, Li, Aimin, Strait, Karen, Zhang, Hongying, Nanes, Mark S, Weitzmann, M Neale·2007·Journal of Bone and Mineral Research

Abstract

Endogenous TNFα prevents the attainment of maximum achievable peak bone mass in vivo. In vitro, TNFα suppresses BMP-2– and TGFβ-mediated Smad activation through induction of NF-κB. Consistently, pharmacological suppression of NF-κB augments osteoblast differentiation and mineralization in vitro. Introduction: Osteoporosis is a major health threat. Traditional therapeutic strategies have centered on anti-catabolic drugs that block bone resorption. Recently focus has shifted to anabolic agents that actively rebuild lost bone mass. Future strategies may involve elevating peak bone mass to delay osteoporosis development. Recent in vitro studies show that TNFα represses osteoblast differentiation and mineralization; however, the mechanisms are poorly understood and the impact of basal TNFα concentrations on the acquisition of peak bone mass in vivo is unknown. Materials and Methods: We examined peak BMD, bone volume, and bone turnover makers in mice deficient in TNFα or its receptors. We further examined the effect of TNFα on Smad-induced signaling by TGFβ and BMP-2 in vitro using a Smad responsive reporter. The effect of TNFα-induced NF-κB signaling on Smad signaling and on in vitro osteoblast mineralization was examined using specific NF-κB inhibitors and activators, and effects of TNFα-induced NF-κB signaling on BMP-2–induced Runx2 mRNA were examined using RT-PCR. Results: Mice null for TNFα or its p55 receptor had significantly increased peak bone mass, resulting exclusively from elevated bone formation. In vitro, TNFα potently suppressed Smad signaling induced by TGFβ and BMP-2, downregulated BMP-2–mediated Runx2 expression, and inhibited mineralization of osteoblasts. These effects were mimicked by overexpression of NF-κB and prevented by pharmacological NF-κB suppression. Conclusions: Our data suggest that TNFα and NF-κB antagonists may represent novel anabolic agents for the maximization of peak basal bone mass and/or the amelioration of pathological bone loss.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1359/jbmr.070121

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 181

Metadata

Authors
Li, Y., Li, A., Strait, K., Zhang, H., Nanes, M. S., & Weitzmann, M. N.
Venue
Journal of Bone and Mineral Research
Published
2007-05-01
Volume
22
Issue
5
Pages
646-655
ISSN
  • 0884-0431 (ISSN-L)
  • 1523-4681
OpenAlex
W2006385099
Cited by
181
References
6
FWCI
2.99
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Endogenous TNFα Lowers Maximum Peak Bone Mass and Inhibits Osteoblastic Smad Activation Through NF-κB. https://app.cochat.ai/papers/10.1359/jbmr.070121
The paper
Li, Y., Li, A., Strait, K., Zhang, H., Nanes, M. S., & Weitzmann, M. N. (2007). Endogenous TNFα Lowers Maximum Peak Bone Mass and Inhibits Osteoblastic Smad Activation Through NF-κB. Journal of Bone and Mineral Research. https://doi.org/10.1359/jbmr.070121

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.